Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Bionano Genomics Q2 2024 GAAP EPS $(0.24) Beats $(0.42) Estimate, Sales $7.771M Miss $8.003M Estimate

Author: Benzinga Newsdesk | August 07, 2024 07:14pm
Bionano Genomics (NASDAQ:BNGO) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.42) by 42.86 percent. This is a 80.65 percent increase over losses of $(1.24) per share from the same period last year. The company reported quarterly sales of $7.771 million which missed the analyst consensus estimate of $8.003 million by 2.90 percent. This is a 10.29 percent decrease over sales of $8.662 million the same period last year.

Posted In: BNGO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist